Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Proximity biotinylation assay with a host protein bait reveals multiple factors modulating enterovirus replication. | PLoS Pathog | 2022 | 36306280 | PubTator, text mining | PubMed |
| Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis. | Front Immunol | 2022 | 36304460 | PubTator, text mining | PubMed |
| Disturbance of the Warburg effect by dichloroacetate and niclosamide suppresses the growth of different sub-types of malignant pleural mesothelioma in vitro and in vivo. | Front Pharmacol | 2022 | 36304150 | PubTator, text mining | PubMed |
| Indole-3-Carbinol Stabilizes p53 to Induce miR-34a, Which Targets LDHA to Block Aerobic Glycolysis in Liver Cancer Cells. | Pharmaceuticals (Basel) | 2022 | 36297369 | PubTator, text mining | PubMed |
| Clinical, Biochemical, and Molecular Characterization of Two Families with Novel Mutations in the LDHA Gene (GSD XI). | Genes (Basel) | 2022 | 36292720 | PubTator, text mining | PubMed |
| Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy. | Cancers (Basel) | 2022 | 36291904 | PubTator, text mining | PubMed |
| High-Resolution Ribosome Profiling Reveals Gene-Specific Details of UGA Re-Coding in Selenoprotein Biosynthesis. | Biomolecules | 2022 | 36291713 | PubTator, text mining | PubMed |
| Crosstalk between Immune Checkpoint Modulators, Metabolic Reprogramming and Cellular Plasticity in Triple-Negative Breast Cancer. | Curr Oncol | 2022 | 36290817 | PubTator, text mining | PubMed |
| Interplay between the m6A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications. | Biomedicines | 2022 | 36289851 | PubTator, text mining | PubMed |
| Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. | EMBO Mol Med | 2022 | 36278433 | PubTator, text mining | PubMed |
| HPV18 oncoproteins driven expression of PKM2 reprograms HeLa cell metabolism to maintain aerobic glycolysis and viability. | Virusdisease | 2022 | 36277414 | PubTator, text mining | PubMed |
| Correlation of Glucose Metabolism with Cancer and Intervention with Traditional Chinese Medicine. | Evid Based Complement Alternat Med | 2022 | 36276846 | PubTator, text mining | PubMed |
| Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma. | Front Immunol | 2022 | 36275729 | PubTator, text mining | PubMed |
| Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells. | Anim Cells Syst (Seoul) | 2022 | 36275445 | PubTator, text mining | PubMed |
| UBE2O promotes lipid metabolic reprogramming and liver cancer progression by mediating HADHA ubiquitination. | Oncogene | 2022 | 36273042 | PubTator, text mining | PubMed |
| Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities. | Cancer Commun (Lond) | 2022 | 36266736 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Cancer Drug Resistance: Roles, Mechanisms, and Implications. | Adv Sci (Weinh) | 2022 | 36253096 | PubTator, text mining | PubMed |
| Natural products targeting human lactate dehydrogenases for cancer therapy: A mini review. | Front Chem | 2022 | 36247675 | PubTator, text mining | PubMed |
| Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19. | iScience | 2022 | 36246577 | PubTator, text mining | PubMed |
| Transcriptomes of Clusterin- and S100B-transfected neuronal cells elucidate protective mechanisms against hypoxia and oxidative stress in the hooded seal (Cystophora cristata) brain. | BMC Neurosci | 2022 | 36243678 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=34